429603001: Maraviroc (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Chemokine receptor antagonist\Maraviroc (substance)
\Substance categorized by disposition\Substance with antiviral mechanism of action (substance)\Substance with antiretroviral mechanism of action (substance)\Human immunodeficiency virus entry inhibitor\Human immunodeficiency virus fusion inhibitor\Maraviroc (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Substance with antiviral mechanism of action (substance)\Substance with antiretroviral mechanism of action (substance)\Human immunodeficiency virus entry inhibitor\Human immunodeficiency virus fusion inhibitor\Maraviroc (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Azole\Substance with triazole structure (substance)\Maraviroc (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Azole\Substance with triazole structure (substance)\Maraviroc (substance)
\Organic compound\Organic nitrogen compound\Azole\Substance with triazole structure (substance)\Maraviroc (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2008. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Maraviroc (substance)	Is a	Triazole derivative	false	Inferred relationship	Some
Maraviroc (substance)	Is a	Chemokine receptor antagonist	true	Inferred relationship	Some
Maraviroc (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Human immunodeficiency virus fusion inhibitor	true	Inferred relationship	Some
Maraviroc (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Chemokine receptor antagonist (disposition)	true	Inferred relationship	Some
Maraviroc (substance)	Is a	Human immunodeficiency virus fusion inhibitor	true	Inferred relationship	Some
Maraviroc (substance)	Is a	Organic fluoride compound	false	Inferred relationship	Some
Maraviroc (substance)	Is a	Fluorine compound	false	Inferred relationship	Some
Maraviroc (substance)	Is a	Substance with triazole structure (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing maraviroc (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Maraviroc (substance)	Inferred relationship	Some	1
Maraviroc 150 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Maraviroc (substance)	Inferred relationship	Some
Maraviroc 300 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Maraviroc (substance)	Inferred relationship	Some
Maraviroc 150 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Maraviroc (substance)	Inferred relationship	Some	1
Maraviroc 150 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Maraviroc (substance)	Inferred relationship	Some	1
Maraviroc 300 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Maraviroc (substance)	Inferred relationship	Some	1
Maraviroc 300 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Maraviroc (substance)	Inferred relationship	Some	1
Maraviroc 300 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Maraviroc (substance)	Inferred relationship	Some	1
Maraviroc 150 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Maraviroc (substance)	Inferred relationship	Some	1
Product containing maraviroc in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Maraviroc (substance)	Inferred relationship	Some	1
Maraviroc only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Maraviroc (substance)	Inferred relationship	Some	1
Product containing only maraviroc in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Maraviroc (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2688602010	Maraviroc (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2696076015	Maraviroc	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
52071000195118	maraviroc	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
822901000172119	maraviroc	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
66371000195114	Maraviroc	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module